MYCOPHENOLATE MOFETIL
Generic: MYCOPHENOLATE MOFETIL
Aurobindo Pharma LimitedManufacturer
ORALRoute
MYCOPHENOLATE MOFETILActive Substance
2024-02-20Original Approval
MYCOPHENOLATE MOFETIL is FDA application ANDA217937, sponsored by AUROBINDO PHARMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class I2019-04-30
Mycophenolate Mofetil for Injection, USP 500 mg, 4 Single Dose Vials, Rx Only, Distributed by: Par Pharmaceutical ChestPresence of Particulate Matter; glass fragment observed in one vial of reconstituted product
Class III2023-10-26
Mycophenolate Mofetil for Oral Suspension, USP, 200 mg/mL, Rx Only, bottle, Manufactured for: VistaPharm, Inc., Largo, FDefective Container: The adaptor does not fit into the neck of the bottle after reconstitution with
Class II2026-07-02
Mycophenolate Mofetil for Injection USP, 500 mg/Vial, Single Dose Vial, 4 vials per carton, Rx only, Manufactured for: MPresence of precipitate
Class II2026-08-26
Carton label: Mycophenolate Mofetil for injection, USP, 500 mg/vial, Sterile, 4 Single Dose Vials, Rx only, ManufacturedFailed Dissolution Specifications
Top Reported Reactions
1
OFF LABEL USE
16,547 reports
2
DRUG INEFFECTIVE
10,445 reports
3
PRODUCT USE IN UNAPPROVED INDICATION
7,053 reports
4
DIARRHOEA
5,237 reports
5
PYREXIA
4,613 reports
6
CYTOMEGALOVIRUS INFECTION
4,476 reports
7
PNEUMONIA
4,419 reports
8
CONDITION AGGRAVATED
3,975 reports
9
TRANSPLANT REJECTION
3,572 reports
10
INFECTION
3,528 reports